Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Ibiden Co., Ltd./ADR
High uncertainty: The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-89.4% vs price
Base Case (Median)
-78.0% vs price
Bull Case (75th pct.)
-72.5% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| DCF (Discounted Cash Flow) | $0.71 | -99.5% | High (40%) |
| PE Comparable | $38.36 | -72.2% | Medium (25%) |
| Growth Trajectory DCF | $37.76 | -72.7% | Medium (20%) |
| Graham Number | $20.27 | -85.3% | Low (10%) |
| EV/EBITDA | $30.44 | -78.0% | Medium (20%) |
| EV/FCF | $43.47 | -68.5% | Medium (20%) |
| Earnings Power Value | $8.99 | -93.5% | Medium (50%) |
Based on 7 out of 7 methods, IBIDF appears overvalued at the current price of $138.20. The base case fair value of $30.44 implies 78.0% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.